Diagnosis and treatment guidelines for hepatocellular carcinoma(2017 Edition): an update and interpretationWANG Chun-ping, REN Bo, LU Yin-ying, HUANG Jia-gan, LI Yin-yin, ZENG Zhen, YANG Bin, GAO Xu-dong, YANG Yong-ping193-196,202
Advance on novel therapeutic agents for chronic hepatitis BLI Yuan-yuan, ZHOU Wen-jing, JIN Jie-hua, WANG Fu-sheng197-202
Advance of causality assessment and biomarker of idiosyncratic drug-induced liver injurySUN Ying, XIE Huan, WANG Chun-hong, ZOU Zheng-sheng203-208
Research progress of pyrrolizidine alkaloids induced liver injuryWEN Liang-zhi, SUN Wen-jing, LIU Kai-jun, WANG Bin, WEI Yan-ling, CHEN Dong-feng, CUI Hong-li209-211,226
Association between CYP2E1 and NAT2 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysisSHENG Yun-jian, HE Hong-yan212-215
Effect of duration of second labor stage on maternal-infant transmission of HBV infected pregnant women and maternal-neonatal outcomes after application of new partogramYIN Ying-hui, WANG Mei216-219
Clinical analysis of cyberknife treatment for 10 primary hepatic carcinoma with pulmonary metastasis patientsLI Huan, SUN Jing, WANG Hui, Zhang Tao, SUN Ying-zhe, FAN Yu-ze, HE Wei-ping, DUAN Xue-zhang220-222
Analysis on influenza surveillance of children in Beijing from 2011 to 2015CHU Yan-hui, SUN Xiao-yu, REN Jian, XIAO Zheng, QIN Di, HUO Yun-yan223-226
Analysis on the epidemiological characteristics of bacillary dysentery in Xinjiang Production and Construction Corps from 2006 to 2015HAN Fei, MA Xiao-ling, ZHAO Yong-nian, YU Ya-le227-229